Cargando…

The utility of (18)F-FDG and (68)Ga-DOTA-Peptide PET/CT in the evaluation of primary pulmonary carcinoid: A systematic review and meta-analysis

BACKGROUND: Pulmonary carcinoids (PC) are histologically classified into typical carcinoid (TC) and atypical carcinoid (AC). The diagnosis of pulmonary carcinoid and possibly the differentiation between TC and AC could make a significant effect on the treatment planning as well as prognosis.([1]) Se...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yuanyuan, Hou, Guozhu, Cheng, Wuying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417554/
https://www.ncbi.nlm.nih.gov/pubmed/30855482
http://dx.doi.org/10.1097/MD.0000000000014769
_version_ 1783403588368728064
author Jiang, Yuanyuan
Hou, Guozhu
Cheng, Wuying
author_facet Jiang, Yuanyuan
Hou, Guozhu
Cheng, Wuying
author_sort Jiang, Yuanyuan
collection PubMed
description BACKGROUND: Pulmonary carcinoids (PC) are histologically classified into typical carcinoid (TC) and atypical carcinoid (AC). The diagnosis of pulmonary carcinoid and possibly the differentiation between TC and AC could make a significant effect on the treatment planning as well as prognosis.([1]) Several studies have explored the utility of (68)Ga-DOTA-Peptide ((68)Ga-labelled [1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid]-peptide) and (18)F-flurodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) in the evaluation of primary pulmonary carcinoids. Therefore, we performed a meta-analysis to evaluate the diagnostic accuracy and prediction efficiency of histological subtypes of these two imaging modalities in primary PC. METHODS: Relevant studies were identified by searching PubMed, Web of Science, and EMBASE published from 2006 to 2016. Two authors extracted characteristics of patients and their lesions using predefined criteria. RESULTS: Fourteen studies comprising 352 patients were included in this meta-analysis. The pooled sensitivity of (68)Ga-DOTA-Peptide and (18)F-FDG PET/CT in detecting pulmonary carcinoid were 90.0% (95% CI = 82.0–95.0%; P = .07; I(2) = 49.6%) and 71.0% (95% CI = 66.0–76.0%; P < .001; I(2) = 59.3%), respectively. An SUVmax ratio between (68)Ga-DOTA-Peptide and (18)F-FDG higher than the cutoff value of 4.28 was predictive of TC with 89.3% sensitivity and 100% specificity (AUC, 96.4%; 95% CI, 91.1–100%). The ratio of tumor uptake to atelectatic lung uptake was significantly higher for (68)Ga-DOTA-peptide (2.5–91, mean 30.5 ± 28.1) than for (18)F-FDG (0.3–10.3, mean 2.1 ± 2.3) (P < .001). CONCLUSIONS: Both (68)Ga-DOTA-peptide and (18)F-FDG are highly sensitive in detecting pulmonary carcinoid, while (68)Ga-DOTA-peptide is more sensitive than (18)F-FDG (90.0% vs 71.0%). The SUVmax ratio was an accurate predictor of the histopathologic variety of the carcinoid tumor, and (68)Ga-DOTA-peptide was better than (18)F-FDG in cases with atelectasis.
format Online
Article
Text
id pubmed-6417554
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-64175542019-03-16 The utility of (18)F-FDG and (68)Ga-DOTA-Peptide PET/CT in the evaluation of primary pulmonary carcinoid: A systematic review and meta-analysis Jiang, Yuanyuan Hou, Guozhu Cheng, Wuying Medicine (Baltimore) Research Article BACKGROUND: Pulmonary carcinoids (PC) are histologically classified into typical carcinoid (TC) and atypical carcinoid (AC). The diagnosis of pulmonary carcinoid and possibly the differentiation between TC and AC could make a significant effect on the treatment planning as well as prognosis.([1]) Several studies have explored the utility of (68)Ga-DOTA-Peptide ((68)Ga-labelled [1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid]-peptide) and (18)F-flurodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) in the evaluation of primary pulmonary carcinoids. Therefore, we performed a meta-analysis to evaluate the diagnostic accuracy and prediction efficiency of histological subtypes of these two imaging modalities in primary PC. METHODS: Relevant studies were identified by searching PubMed, Web of Science, and EMBASE published from 2006 to 2016. Two authors extracted characteristics of patients and their lesions using predefined criteria. RESULTS: Fourteen studies comprising 352 patients were included in this meta-analysis. The pooled sensitivity of (68)Ga-DOTA-Peptide and (18)F-FDG PET/CT in detecting pulmonary carcinoid were 90.0% (95% CI = 82.0–95.0%; P = .07; I(2) = 49.6%) and 71.0% (95% CI = 66.0–76.0%; P < .001; I(2) = 59.3%), respectively. An SUVmax ratio between (68)Ga-DOTA-Peptide and (18)F-FDG higher than the cutoff value of 4.28 was predictive of TC with 89.3% sensitivity and 100% specificity (AUC, 96.4%; 95% CI, 91.1–100%). The ratio of tumor uptake to atelectatic lung uptake was significantly higher for (68)Ga-DOTA-peptide (2.5–91, mean 30.5 ± 28.1) than for (18)F-FDG (0.3–10.3, mean 2.1 ± 2.3) (P < .001). CONCLUSIONS: Both (68)Ga-DOTA-peptide and (18)F-FDG are highly sensitive in detecting pulmonary carcinoid, while (68)Ga-DOTA-peptide is more sensitive than (18)F-FDG (90.0% vs 71.0%). The SUVmax ratio was an accurate predictor of the histopathologic variety of the carcinoid tumor, and (68)Ga-DOTA-peptide was better than (18)F-FDG in cases with atelectasis. Wolters Kluwer Health 2019-03-08 /pmc/articles/PMC6417554/ /pubmed/30855482 http://dx.doi.org/10.1097/MD.0000000000014769 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle Research Article
Jiang, Yuanyuan
Hou, Guozhu
Cheng, Wuying
The utility of (18)F-FDG and (68)Ga-DOTA-Peptide PET/CT in the evaluation of primary pulmonary carcinoid: A systematic review and meta-analysis
title The utility of (18)F-FDG and (68)Ga-DOTA-Peptide PET/CT in the evaluation of primary pulmonary carcinoid: A systematic review and meta-analysis
title_full The utility of (18)F-FDG and (68)Ga-DOTA-Peptide PET/CT in the evaluation of primary pulmonary carcinoid: A systematic review and meta-analysis
title_fullStr The utility of (18)F-FDG and (68)Ga-DOTA-Peptide PET/CT in the evaluation of primary pulmonary carcinoid: A systematic review and meta-analysis
title_full_unstemmed The utility of (18)F-FDG and (68)Ga-DOTA-Peptide PET/CT in the evaluation of primary pulmonary carcinoid: A systematic review and meta-analysis
title_short The utility of (18)F-FDG and (68)Ga-DOTA-Peptide PET/CT in the evaluation of primary pulmonary carcinoid: A systematic review and meta-analysis
title_sort utility of (18)f-fdg and (68)ga-dota-peptide pet/ct in the evaluation of primary pulmonary carcinoid: a systematic review and meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417554/
https://www.ncbi.nlm.nih.gov/pubmed/30855482
http://dx.doi.org/10.1097/MD.0000000000014769
work_keys_str_mv AT jiangyuanyuan theutilityof18ffdgand68gadotapeptidepetctintheevaluationofprimarypulmonarycarcinoidasystematicreviewandmetaanalysis
AT houguozhu theutilityof18ffdgand68gadotapeptidepetctintheevaluationofprimarypulmonarycarcinoidasystematicreviewandmetaanalysis
AT chengwuying theutilityof18ffdgand68gadotapeptidepetctintheevaluationofprimarypulmonarycarcinoidasystematicreviewandmetaanalysis
AT jiangyuanyuan utilityof18ffdgand68gadotapeptidepetctintheevaluationofprimarypulmonarycarcinoidasystematicreviewandmetaanalysis
AT houguozhu utilityof18ffdgand68gadotapeptidepetctintheevaluationofprimarypulmonarycarcinoidasystematicreviewandmetaanalysis
AT chengwuying utilityof18ffdgand68gadotapeptidepetctintheevaluationofprimarypulmonarycarcinoidasystematicreviewandmetaanalysis